1000 related articles for article (PubMed ID: 10874261)
1. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
[TBL] [Abstract][Full Text] [Related]
2. Different effects on circulatory control during volatile induction and maintenance of anesthesia and total intravenous anesthesia: autonomic nervous activity and arterial cardiac baroreflex function evaluated by blood pressure and heart rate variability analysis.
Ogawa Y; Iwasaki K; Shibata S; Kato J; Ogawa S; Oi Y
J Clin Anesth; 2006 Mar; 18(2):87-95. PubMed ID: 16563324
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans.
Heindl S; Holzschneider J; Hinz A; Sayk F; Fehm HL; Dodt C
J Neuroendocrinol; 2006 Feb; 18(2):115-21. PubMed ID: 16420280
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.
De Tommasi E; Iacoviello M; Romito R; Ceconi C; Guida P; Massari F; Francolini G; Bertocchi F; Ferrari R; Rizzon P; Pitzalis MV
Am Heart J; 2003 Nov; 146(5):E17. PubMed ID: 14597946
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and cardiac parasympathetic control in human heart failure.
Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
[TBL] [Abstract][Full Text] [Related]
7. Effect of verapamil on baroreflex sensitivity and on cardiovascular variability.
Gmitrov J; Andrejko S
Wien Klin Wochenschr; 2000 Feb; 112(4):162-8. PubMed ID: 10726329
[TBL] [Abstract][Full Text] [Related]
8. Circadian heart rate variability in patients with primary arterial hypertension.
Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
[TBL] [Abstract][Full Text] [Related]
9. Direct angiotensin converting enzyme inhibitor-mediated venodilation.
Zarnke KB; Feldman RD
Clin Pharmacol Ther; 1996 May; 59(5):559-68. PubMed ID: 8646827
[TBL] [Abstract][Full Text] [Related]
10. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure.
Evans MA; Burnett JC; Redfield MM
J Am Coll Cardiol; 1995 May; 25(6):1445-50. PubMed ID: 7722147
[TBL] [Abstract][Full Text] [Related]
11. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
Wu RA; Kailasam MT; Cervenka JH; Parmer RJ; Kennedy BP; Ziegler MG; O'Connor DT
J Hypertens; 1994 Nov; 12(11):1243-7. PubMed ID: 7868871
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute angiotensin converting enzyme inhibition on left ventricular filling in patients with congestive heart failure. Relation to right ventricular volumes.
Konstam MA; Kronenberg MW; Udelson JE; Metherall J; Dolan N; Edens TR; Howe DM; Yusuf S; Youngblood M; Toltsis H
Circulation; 1990 Feb; 81(2 Suppl):III115-22. PubMed ID: 2153478
[TBL] [Abstract][Full Text] [Related]
13. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
14. The effect of the year angiotensin-converting enzyme inhibitors (ACE I) intake on circadian heart rate variability in patients with primary hypertension.
Banach T; Kolasińska-Kloch W; Furgała A; Laskiewicz J
Folia Med Cracov; 2001; 42(3):129-40. PubMed ID: 12353420
[TBL] [Abstract][Full Text] [Related]
15. [Spontaneous baroreflex control of heart rate during chronic tandropril therapy].
Raimondi G; Iellamo F; Legramante JM; Massaro M; Cassarino S; Micozzi F; Peruzzi G
Cardiologia; 1998 Apr; 43(4):395-401. PubMed ID: 9659797
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure.
Vaile JC; Chowdhary S; Osman F; Ross HF; Fletcher J; Littler WA; Coote JH; Townend JN
Clin Sci (Lond); 2001 Dec; 101(6):559-66. PubMed ID: 11724639
[TBL] [Abstract][Full Text] [Related]
17. Baroreflex mechanisms in major depression.
Davydov DM; Shapiro D; Cook IA; Goldstein I
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):164-77. PubMed ID: 17011098
[TBL] [Abstract][Full Text] [Related]
18. Limited utility of the phenylephrine-nitroprusside sigmoid curve method of measuring baroreflex function after myocardial infarction.
Leitch JW; Newling R; Nyman E; Cox K; Dear K
J Cardiovasc Risk; 1997 Jun; 4(3):179-84. PubMed ID: 9475672
[TBL] [Abstract][Full Text] [Related]
19. Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure.
Osterziel KJ; Dietz R
J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S25-30. PubMed ID: 8723396
[TBL] [Abstract][Full Text] [Related]
20. Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors.
Menezes Ada S; Moreira HG; Daher MT
Arq Bras Cardiol; 2004 Aug; 83(2):169-72; 165-8. PubMed ID: 15322659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
